Preferred Label : METMAB Score;
NCIt definition : The histopathological evaluation of MET staining in tissue based on the METMAB scoring
system. (Spigel DR, Ervin TJ, Ramlau RA, et al. Randomized phase II trial of Onartuzumab
in combination with erlotinib in patients with advanced non-small-cell lung cancer.
J Clin Oncol. 2013;31:4105-14.);
Alternative definition : CDISC: The histopathological evaluation of MET (Hepatocyte Growth Factor Receptor)
staining in tissue based on the METMAB scoring system (Koeppen H, Yu W, Zha J, et
al. Biomarker Analyses from a Placebo-Controlled Phase II Study Evaluating Erlotinib
/- Onartuzumab in Advanced Non-Small Cell Lung Cancer: MET Expression Levels Are Predictive
of Patient Benefit. Clin Cancer Res. 2014 September 1; 20(17): 4488-4498.);
NCI Metathesaurus CUI : CL1411733;
Origin ID : C174344;
UMLS CUI : C5420719;
Semantic type(s)
- concept_is_in_subset
